Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,072 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PRRT2 deficiency induces paroxysmal kinesigenic dyskinesia by regulating synaptic transmission in cerebellum.
Tan GH, Liu YY, Wang L, Li K, Zhang ZQ, Li HF, Yang ZF, Li Y, Li D, Wu MY, Yu CL, Long JJ, Chen RC, Li LX, Yin LP, Liu JW, Cheng XW, Shen Q, Shu YS, Sakimura K, Liao LJ, Wu ZY, Xiong ZQ. Tan GH, et al. Among authors: wu zy, wu my. Cell Res. 2018 Jan;28(1):90-110. doi: 10.1038/cr.2017.128. Epub 2017 Oct 20. Cell Res. 2018. PMID: 29056747 Free PMC article.
X-linked microtubule-associated protein, Mid1, regulates axon development.
Lu T, Chen R, Cox TC, Moldrich RX, Kurniawan N, Tan G, Perry JK, Ashworth A, Bartlett PF, Xu L, Zhang J, Lu B, Wu M, Shen Q, Liu Y, Richards LJ, Xiong Z. Lu T, et al. Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):19131-6. doi: 10.1073/pnas.1303687110. Epub 2013 Nov 5. Proc Natl Acad Sci U S A. 2013. PMID: 24194544 Free PMC article.
Prevention and management of cytomegalovirus infection and disease in kidney transplant: A consensus statement of the Transplantation Society of Taiwan.
Chung MC, Chen CH, Chang SS, Lee CY, Tian YC, Wu MY, Wang HH, Yu CC, Chen TW, Kao CC, Hsu CY, Chiang YJ, Wu MJ, Chen YT, Wu MS. Chung MC, et al. Among authors: wu my. J Formos Med Assoc. 2024 May 21:S0929-6646(24)00245-6. doi: 10.1016/j.jfma.2024.05.009. Online ahead of print. J Formos Med Assoc. 2024. PMID: 38777672 Review.
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial.
Goodyear CS, Patel A, Barnes E, Willicombe M, Siebert S, de Silva TI, Snowden JA, Lim SH, Bowden SJ, Billingham L, Richter A, Carroll M, Carr EJ, Beale R, Rea D, Parry H, Pirrie S, Lim Z, Satsangi J, Dunachie SJ, Cook G, Miller P, Basu N, Gilmour A, Hodgkins AM, Evans L, Hughes A, Longet S, Meacham G, Yong KL, A'Hearne MJ, Koh MBC, Burns SO, Orchard K, Paterson C, McIlroy G, Murray SM, Thomson T, Dimitriadis S, Goulston L, Miller S, Keillor V, Prendecki M, Thomas D, Kirkham A, McInnes IB, Kearns P; OCTAVE-DUO investigators. Goodyear CS, et al. Lancet Rheumatol. 2024 Jun;6(6):e339-e351. doi: 10.1016/S2665-9913(24)00065-1. Epub 2024 May 8. Lancet Rheumatol. 2024. PMID: 38734019 Free article. Clinical Trial.
CSF-1R: A promising therapeutic target for various diseases.
Wen CY, Chen PH, Hsieh FR, Chang R, Wu MY, Yong SB, Li CJ. Wen CY, et al. Among authors: wu my. Pharmacol Res. 2024 Apr 25;204:107196. doi: 10.1016/j.phrs.2024.107196. Online ahead of print. Pharmacol Res. 2024. PMID: 38677533 Free article. No abstract available.
1,072 results